Explore

Trendline Trendline
Precision BioSciences Announces Leadership Changes to Advance Clinical Programs

Precision BioSciences Announces Leadership Changes to Advance Clinical Programs

Precision BioSciences Announces Leadership Changes to Advance Clinical Programs
Trendline Trendline
GeoVax Labs Reports Q2 Loss and Advances Vaccine Study

GeoVax Labs Reports Q2 Loss and Advances Vaccine Study

GeoVax Labs Reports Q2 Loss and Advances Vaccine Study
Trendline Trendline
Goldman Sachs Alternatives Acquires Majority Stake in Numantec for Global Expansion

Goldman Sachs Alternatives Acquires Majority Stake in Numantec for Global Expansion

Goldman Sachs Alternatives Acquires Majority Stake in Numantec for Global Expansion
Trendline Trendline
FDA Deems Replimune's Melanoma Data 'Not Interpretable,' Setting Stage for Challenging Advisory Meeting

FDA Deems Replimune's Melanoma Data 'Not Interpretable,' Setting Stage for Challenging Advisory Meeting

FDA Deems Replimune's Melanoma Data 'Not Interpretable,' Setting Stage for Challenging Advisory Meeting
Trendline Trendline
CSL Announces Positive Phase 3b Results for ANDEMBRY in Pediatric Hereditary Angioedema

CSL Announces Positive Phase 3b Results for ANDEMBRY in Pediatric Hereditary Angioedema

CSL Announces Positive Phase 3b Results for ANDEMBRY in Pediatric Hereditary Angioedema
Trendline Trendline
Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio

Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio

Tonix Pharmaceuticals to Announce Q2 2026 Financial Results Amid Expanding Treatment Portfolio
Trendline Trendline
Sarepta Therapeutics Names Michael Severino as CEO Amid Leadership Transition

Sarepta Therapeutics Names Michael Severino as CEO Amid Leadership Transition

Sarepta Therapeutics Names Michael Severino as CEO Amid Leadership Transition
Trendline Trendline
Ascletis Reports Superior Weight Loss Results for ASC37 in Obese Mouse Model

Ascletis Reports Superior Weight Loss Results for ASC37 in Obese Mouse Model

Ascletis Reports Superior Weight Loss Results for ASC37 in Obese Mouse Model
Trendline Trendline
Argenx Acquires Forte Biosciences for $2.2 Billion to Enhance Immunology Portfolio

Argenx Acquires Forte Biosciences for $2.2 Billion to Enhance Immunology Portfolio

Argenx Acquires Forte Biosciences for $2.2 Billion to Enhance Immunology Portfolio
Trendline Trendline
Dasher Neuroscience Completes Enrollment for Phase 2 Trial of AI Drug for MSA

Dasher Neuroscience Completes Enrollment for Phase 2 Trial of AI Drug for MSA

Dasher Neuroscience Completes Enrollment for Phase 2 Trial of AI Drug for MSA
Trendline Trendline
Yarrow Bioscience Completes Merger with VYNE Therapeutics, Advances Treatment for Thyroid Diseases

Yarrow Bioscience Completes Merger with VYNE Therapeutics, Advances Treatment for Thyroid Diseases

Yarrow Bioscience Completes Merger with VYNE Therapeutics, Advances Treatment for Thyroid Diseases
Trendline Trendline
Yarrow Bioscience Completes Merger with VYNE Therapeutics and Begins Phase 2a/2b Trial for Graves' Disease Treatment

Yarrow Bioscience Completes Merger with VYNE Therapeutics and Begins Phase 2a/2b Trial for Graves' Disease Treatment

Yarrow Bioscience Completes Merger with VYNE Therapeutics and Begins Phase 2a/2b Trial for Graves' Disease Treatment